In August 2015, Amgen and Novartis entered into a global collaboration to develop and commercialize pioneering treatments in the field of Neuroscience. At the center of the Amgen and Novartis collaboration is the shared mission to fight migraine and the stereotypes and misperceptions surrounding this debilitating disease.